Evotec and CHDI Foundation expand ongoing collaboration to fight Huntington's disease

03-Sep-2015 - Germany

Evotec AG announced that CHDI Foundation, Inc. has extended and expanded its collaboration with Evotec through to August 2018. Over this period CHDI will fund 55 full-time scientists at Evotec. The collaboration-which aims to find new treatments for Huntington's disease, an inherited neurodegenerative disorder-will take advantage of additional technologies, capabilities and capacities at Evotec's facilities in Toulouse, France, and Princeton, NJ, USA.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances